Project Grant HT94252510241
Award Date
9/1/25
Completion Date
8/31/27
Dollars Obligated
$234K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Richardson, TX 75080, USA
Similar Awards
The University of Texas at Dallas was awarded a $156,000 Project Grant from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will fund research from March 1, 2023 to February 28, 2025 to develop noninvasive diagnostic imaging techniques for aberrant sarcosine biochemistry in prostate cancer. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with the goals of...
This Project Grant award of $1,229,936, provided by the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), supports advanced biomedical research at The University of Texas Southwestern Medical Center (UT Southwestern) to investigate the metabolic interplay of glutamine and aspartate in renal cell carcinoma (RCC) using imaging strategies and biomarkers. The award, effective from August 1, 2025 through July 31, 2029, will enable UT Southwestern...
This $834,798 federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports PET imaging research of HIF 2A in renal cancer at The University of Texas Southwestern Medical Center in Dallas, Texas. The research project aims to develop new diagnostic and treatment approaches for kidney cancer, which is a key focus area for this Defense Department program. The award will fund basic, translational, and clinical research...
The U.S. Department of Defense's Defense Health Agency awarded a $395,202 Project Grant to The University of Texas Southwestern Medical Center in Dallas, Texas under the Military Medical Research and Development program (CFDA 12.420). The grant, titled "PET IMAGING OF HIF 2A IN RENAL CANCER," supports research to develop new imaging techniques for detecting and monitoring kidney cancer in military personnel and veterans. The three-year award, running from September 1, 2023 to August...
This Project Grant award, valued at $159,341 and awarded on September 30, 2024, is funded through the Military Medical Research and Development program (CFDA 12.420) of the U.S. Department of the Army Medical Command. The grant supports research at The University of Texas Southwestern Medical Center in Dallas, Texas to target the PARP1 protein as a means of overcoming castration resistance in prostate cancer. The research aims to advance new treatment approaches for this condition, which is a...
The University of Texas Southwestern Medical Center was awarded a $1,467,321 project grant from the Defense Health Agency under the Military Medical Research and Development program. The grant will fund research from August 1, 2023 to July 31, 2026 to investigate the mechanisms controlling the progression of prostate adenocarcinoma to neuroendocrine cancer. As part of its mission to transform military and public health through innovative medical research solutions, the Defense Health Agency...
The University of Texas at Dallas (UTD) was awarded a $701,946 Project Grant from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant, awarded on September 1, 2024, will support research to "TARGET MNK SIGNALING TO PREVENT AND REVERSE CHRONIC PAIN CAUSED BY COMPLEX TRAUMATIC INJURY" over a 4-year period ending on August 31, 2028. As a leading research university, UTD will leverage its expertise in areas such as...
This $1,124,825 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) will support research at the University of Texas Health Science Center at San Antonio (UTHSCSA) to identify novel therapeutic targets for aggressive prostate cancer through induced pluripotent stem cell modeling of BRCA2 mutant prostate tissue. The award, which runs from August 1, 2024 to July 31, 2027, will enable UTHSCSA to conduct innovative scientific...
The Defense Health Agency awarded a $1.1 million project grant to the University of Texas Southwestern Medical Center in Dallas, Texas, to support research under the Military Medical Research and Development program. The three-year award beginning in June 2023 will fund the development of a multifunctional immunotherapy nanoparticle to enable innate immunotherapy for kidney cancer. As the prime awardee, UT Southwestern will leverage its expertise in oncology and immunology to advance this...
The federal Project Grant award, with ID HT94252410992, was provided by the Defense Health Agency (DHA) under the Military Medical Research and Development (CFDA 12.420) federal grant program. The award, totaling $2,710,479.00, will fund a research initiative led by the University of Texas M.D. Anderson Cancer Center to advance the understanding of metastatic breast cancer through the development of a comprehensive research platform. The award's performance period is from August 15, 2024 to...